Literature DB >> 27240287

Clinical importance of bilateral disease in patients with papillary thyroid cancer.

Sarah E Moore1, Katayoon Kasaian1, Steven Jones1, Adrienne Melck1, Sam M Wiseman1.   

Abstract

ABSTRACT: A cancer-related factor that is not included in papillary thyroid cancer (PTC) prognostic scoring systems is bilaterality. While it may seem that bilaterality should be considered during the management of PTC, its clinical importance has been debated. This controversy exists because the extent of surgery for PTC has not been found to affect survival in low-risk individuals, despite their potential for PTC bilaterality. We sought to determine if PTC bilaterality is a cancer prognosticator based upon its association with known clinical and pathological PTC prognosticators, and MACIS scores. In this article we discuss our findings and their potential clinical implications.

Entities:  

Mesh:

Year:  2016        PMID: 27240287      PMCID: PMC4982867          DOI: 10.1503/cjs.014615

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  5 in total

Review 1.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

2.  Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma.

Authors:  Mona Bansal; Manoj Gandhi; Robert L Ferris; Marina N Nikiforova; Linwah Yip; Sally E Carty; Yuri E Nikiforov
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

3.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

Authors:  I D Hay; E J Bergstralh; J R Goellner; J R Ebersold; C S Grant
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

4.  Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.

Authors:  Mohamed Abdelgadir Adam; John Pura; Lin Gu; Michaela A Dinan; Douglas S Tyler; Shelby D Reed; Randall Scheri; Sanziana A Roman; Julie A Sosa
Journal:  Ann Surg       Date:  2014-10       Impact factor: 12.969

5.  Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.

Authors:  Eun Sook Kim; Tae Yong Kim; Jung Min Koh; Young Il Kim; Suck Joon Hong; Won Bae Kim; Young Kee Shong
Journal:  Clin Endocrinol (Oxf)       Date:  2004-07       Impact factor: 3.478

  5 in total
  1 in total

1.  Risk Factors for Central Lymph Node Metastases and Benefit of Prophylactic Central Lymph Node Dissection in Middle Eastern Patients With cN0 Papillary Thyroid Carcinoma.

Authors:  Sandeep Kumar Parvathareddy; Abdul K Siraj; Saeeda O Ahmed; Felisa DeVera; Saif S Al-Sobhi; Fouad Al-Dayel; Khawla S Al-Kuraya
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.